Global COVID-19 Vaccines Research Report 2023-2025 - Licensing and Partnership Deals Worldwide Propel Vaccine Production
April 22, 2024 06:22 ET
|
Research and Markets
Dublin, April 22, 2024 (GLOBE NEWSWIRE) -- The "COVID-19 Vaccines - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global COVID-19 Vaccines Market to...
AAV Vectors in Gene Therapy Pipeline Landscape Report 2024: Comprehensive Insights about 70+ Companies and 235+ Pipeline Drugs
April 19, 2024 07:31 ET
|
Research and Markets
Dublin, April 19, 2024 (GLOBE NEWSWIRE) -- The "AAV vectors in gene therapy - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering.This "AAV vectors in gene...
Viral Vector and Plasmid DNA Technologies Market Outlook 2024-2028: Innovations, Technological Advances and Product Launches from Leading Companies
April 05, 2024 04:02 ET
|
Research and Markets
Dublin, April 05, 2024 (GLOBE NEWSWIRE) -- The "Viral Vector and Plasmid DNA: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering. The global market for...
Vaccine Research Report 2024: Global Trends, Opportunities and Competitive Analysis to 2030 Featuring GlaxoSmithKline, Merck, Pfizer, Sanofi, and CSL
March 11, 2024 11:26 ET
|
Research and Markets
Dublin, March 11, 2024 (GLOBE NEWSWIRE) -- The "Vaccine Market: Trends, Opportunities and Competitive Analysis [2024-2030]" report has been added to ResearchAndMarkets.com's offering.The global...
Global Viral Vector and Plasmid DNA Manufacturing Market Report 2023-2028: Industry Forecasted at $10.14 Billion by 2028, Dominated by Oxford Biomedica, Cognate BioServices, and Cell & Gene Therapy Catapult
February 20, 2024 04:03 ET
|
Research and Markets
Dublin, Feb. 20, 2024 (GLOBE NEWSWIRE) -- The "Viral Vector and Plasmid DNA Manufacturing Market - Global Industry Size, Share, Trends Opportunity, and Forecast 2018-2028" report has been added to ...
Global Biologics Contract Manufacturing Research Report 2022-2023 and 2023-2035: Biologics CMO Made Considerable Investments to Expand Facilities, With Some CMOs Re-evaluating Capacity Investments
February 20, 2024 04:01 ET
|
Research and Markets
Dublin, Feb. 20, 2024 (GLOBE NEWSWIRE) -- The "Global Biologics Contract Manufacturing (Biopharma CDMO/Biopharma CMO/Biologics Manufacturing) Market 2022-2035 by Type of Service(s) Offered, Type of...
Global RNAi Technology Market Projected to Reach $1.9 Billion by 2028: Precision Medicine Integration Accelerating Personalized Treatments
February 12, 2024 04:24 ET
|
Research and Markets
Dublin, Feb. 12, 2024 (GLOBE NEWSWIRE) -- The "RNAi Technology Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2028F" report has been added to ResearchAndMarkets.com's...
Genome Editing Market Report 2024: CRISPR/Cas9 are the Most Sought Genome Editing Tools
February 09, 2024 04:02 ET
|
Research and Markets
Dublin, Feb. 09, 2024 (GLOBE NEWSWIRE) -- The "Global Genome Editing Market, 2023-2035: Focus on Technology, Industry Trends and Forecasts" report has been added to ResearchAndMarkets.com's...
Global CRISPR Genomic Cure Market Set to Soar with 29.21% CAGR till 2028, Driven by Tech Advancements and Therapeutic Expansion
February 08, 2024 10:00 ET
|
Research and Markets
Dublin, Feb. 08, 2024 (GLOBE NEWSWIRE) -- The "Crispr Genomic Cure Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028" report has been added to ...
Global Viral Sensitizers Market Research Report 2023-2035: Development of Gene Therapy Breakthroughs and Surging Demand for Vaccines Emerge as Key Drivers
February 06, 2024 04:00 ET
|
Research and Markets
Dublin, Feb. 06, 2024 (GLOBE NEWSWIRE) -- The "Viral Sensitizers Market: Distribution by Application Area (Viral Vaccines, Oncolytic Viral Therapies and Viral Vectors) and Key Geographical Regions...